Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis - Concepedia

Concepedia

Publication | Closed Access

Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis

47

Citations

23

References

2016

Year

Ruo-Xi Wang, Sheng Chen, Xi Jin, Can-Ming Chen, Zhi‐Ming Shao

Breast Cancer Research and Treatment

Breast OncologyMedicineHer2 AmplificationPathologyWeekly PaclitaxelBreast CancerCancer TreatmentOncologyRadiation OncologyHer2-positive Breast Cancer

References

	Year	Citations

Page 1